Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, June 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 119 articles:
HTML format


 

Single Articles

  1. AGARWAL M, Kardos A
    A case report: biventricular takotsubo cardiomyopathy with sequential ventricular recovery due to pulmonary hypertension.
    Eur Heart J Case Rep. 2021;5:ytab073.
    PubMed    
    Abstract available

  2. CAO Y, Singh V, Jiang N, Wei R, et al
    Stenting for pulmonary artery stenosis resistant to balloon pulmonary angioplasty in chronic thrombo-embolic pulmonary hypertension: a bail out strategy.
    Eur Heart J Case Rep. 2021;5:ytab071.
    PubMed    


  3. THORE P, Jais X, Savale L, Dorfmuller P, et al
    Pulmonary Hypertension in Patients with Common Variable Immunodeficiency.
    J Clin Immunol. 2021 Jun 10. pii: 10.1007/s10875-021-01064.
    PubMed    
    Abstract available

  4. OLIVEIRA LFTS, Chiavegato LD, Arakaki JSO, Reis AOS, et al
    Prevalence of sexual dysfunction in women with pulmonary hypertension and associated factors.
    Heart Lung. 2021;50:714-719.
    PubMed    
    Abstract available

  5. PICCARI L, Bernardo RJ, Rodriguez-Chiaradia D, Vitulo P, et al
    Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?
    Pulm Circ. 2021;11:20458940211018074.
    PubMed    


  6. YAN L, Shi W, Liu Z, Zhao Z, et al
    The benefit of exercise-based rehabilitation programs in patients with pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials.
    Pulm Circ. 2021;11:20458940211007810.
    PubMed    
    Abstract available

  7. MAHMUD E, Patel M, Ang L, Poch D, et al
    Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2021;11:20458940211007385.
    PubMed    
    Abstract available

  8. KLIGERMAN S, Hsiao A
    Optimizing the diagnosis and assessment of chronic thromboembolic pulmonary hypertension with advancing imaging modalities.
    Pulm Circ. 2021;11:20458940211007375.
    PubMed    
    Abstract available

  9. KIM NH, Papamatheakis DG, Fernandes TM
    Evolution of randomized, controlled studies of medical therapy in chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2021;11:20458940211007373.
    PubMed    
    Abstract available

  10. MADANI MM
    Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the-art 2020.
    Pulm Circ. 2021;11:20458940211007372.
    PubMed    
    Abstract available

  11. BUNCLARK K, Doughty N, Michael A, Abraham N, et al
    A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension.
    Pulm Circ. 2021;11:2045894021995055.
    PubMed    
    Abstract available

  12. AVULA SK, Verma S, Ram A, Lankala R, et al
    Rare cause of neonatal pulmonary hypertension: Congenital intrahepatic portosystemic shunt through an aneurysm.
    Ann Pediatr Cardiol. 2021;14:220-223.
    PubMed    
    Abstract available

  13. HNATJUK M, Tatarchuk L, Kritsak M, Konovalenko S, et al
    [MORPHOMETRIC ASSESSMENT OF PECULIARITIES OF BLOOD VESSELS OF THE TESTIS IN EXPERIMENTAL ANIMALS AT ARTERIAL HYPERTENSION IN A LITTLE CIRCLE OF CIRCULATION].
    Georgian Med News. 2021;:163-168.
    PubMed    
    Abstract available

  14. HUANG W, Liu H, Pan Y, Yang H, et al
    Correction to: Mechanical stretching of the pulmonary vein mediates pulmonary hypertension due to left heart disease by regulating SAC/ MAPK pathway and the expression of IL-6 and TNF-alpha.
    J Cardiothorac Surg. 2021;16:169.
    PubMed    


  15. LIU J, Ma S, Ji Q, Cao C, et al
    The role of pulmonary mast cells activation and degranulation in the process of increased pulmonary artery pressure.
    Gen Physiol Biophys. 2021;40:183-195.
    PubMed    
    Abstract available

  16. CASTRO G
    Safety and efficacy of balloon pulmonary angioplasty in a Portuguese pulmonary hypertension expert center: A step in the right direction.
    Rev Port Cardiol. 2021 Jun 4. pii: S0870-2551(21)00221.
    PubMed    


  17. BRUGGER N, Lichtblau M, Maeder M, Muller H, et al
    Two-dimensional transthoracic echocardiography at rest for the diagnosis, screening and management of pulmonary hypertension.
    Swiss Med Wkly. 2021;151:w20486.
    PubMed    
    Abstract available

  18. SALVI D, Poffley E, Tarassenko L, Orchard E, et al
    App-Based Versus Standard Six-Minute Walk Test in Pulmonary Hypertension: Mixed Methods Study.
    JMIR Mhealth Uhealth. 2021;9:e22748.
    PubMed    
    Abstract available

  19. DONEPUDI R, Belfort MA, Shamshirsaz AA, Lee TC, et al
    Fetal endoscopic tracheal occlusion and pulmonary hypertension in moderate congenital diaphragmatic hernia.
    J Matern Fetal Neonatal Med. 2021 Jun 6:1-6. doi: 10.1080/14767058.2021.1932806.
    PubMed    
    Abstract available

  20. ZHU YJ, Zhou YP, Wei YP, Xu XQ, et al
    Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension.
    Front Cardiovasc Med. 2021;8:628284.
    PubMed    
    Abstract available

  21. WALSH TP, Baird GL, Atalay MK, Agarwal S, et al
    Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial.
    Pulm Circ. 2021;11:2045894021989554.
    PubMed    
    Abstract available

  22. BALMOR GR, Segel MJ, Fefer P, Maor E, et al
    Echocardiographic Ventricular Septal Motion Abnormalities are Associated With Pre-Capillary Pulmonary Hypertension in Patients With Preserved Left Ventricular Function.
    Heart Lung Circ. 2021 Jun 1. pii: S1443-9506(21)00424.
    PubMed    
    Abstract available

  23. YING M, Song J, Gu S, Zhao R, et al
    Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis.
    Medicine (Baltimore). 2021;100:e26211.
    PubMed    
    Abstract available

  24. LUI JK, Sangani RA, Chen CA, Bujor AM, et al
    The Prognostic Value of Cardiac Axis Deviation in Systemic Sclerosis-related Pulmonary Hypertension.
    Arthritis Care Res (Hoboken). 2021 Jun 3. doi: 10.1002/acr.24724.
    PubMed    
    Abstract available

  25. HYLDEBRANDT JA, Bogh N, Omann C, Agger P, et al
    Norepinephrine and dobutamine improve cardiac index equally by supporting opposite sides of the heart in an experimental model of chronic pulmonary hypertension.
    Intensive Care Med Exp. 2021;9:29.
    PubMed    
    Abstract available

  26. CHEMLA D, Berthelot E, Weatherald J, Lau EMT, et al
    The isobaric pulmonary arterial compliance in pulmonary hypertension.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available


  27. Title Page: Sharing Progress in Neonatology (SPIN): Oxygen and Surfactant, Optimal Ventilation, Pulmonary Hypertension, Diagnostic Procedures and Definition of Bronchopulmonary Dysplasia.
    Neonatology. 2021;118:206.
    PubMed    


  28. JASINSKA-STROSCHEIN M
    A review of rodent models for metabolic syndromes and pulmonary hypertension.
    Toxicol Appl Pharmacol. 2021;425:115599.
    PubMed    
    Abstract available

  29. JORDENS MS, Luedde M, Roderburg C, Demir M, et al
    Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients.
    J Intern Med. 2021 Jun 3. doi: 10.1111/joim.13337.
    PubMed    
    Abstract available

  30. KIM HY, Kim KH
    How to Determine Right Ventricular Dysfunction in Pulmonary Hypertension.
    J Cardiovasc Imaging. 2021 Apr 14. pii: 29.e41. doi: 10.4250/jcvi.2021.0035.
    PubMed    


  31. PRIETO O, Cianciulli TF, Stewart-Harris A, Rodriguez A, et al
    Speckle Tracking Imaging in Patients with Pulmonary Hypertension.
    J Cardiovasc Imaging. 2021 Mar 18. pii: 29.e31. doi: 10.4250/jcvi.2020.0192.
    PubMed    
    Abstract available

  32. MENON AA, Ruopp NF, Parakh A, Cockrill B, et al
    A Woman with a Repaired Atrial Septal Defect and Pulmonary Hypertension with Worsening Dyspnea.
    Ann Am Thorac Soc. 2021;18:1052-1058.
    PubMed    


  33. LEE EH, Baek S
    Plasticity and Enzymatic Degradation Coupled with Volumetric Growth in Pulmonary Hypertension Progression.
    J Biomech Eng. 2021 Jun 2. pii: 1109881. doi: 10.1115/1.4051383.
    PubMed    
    Abstract available

  34. IMBALZANO E, Vatrano M, Lo Gullo A, Orlando L, et al
    Prevalence of Pulmonary Hypertension in an Unselected Community-Based Population: A Retrospective Echocardiographic Study-RES-PH Study.
    J Pers Med. 2021;11.
    PubMed    
    Abstract available

  35. KOSTYUNINA DS, McLoughlin P
    Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes.
    Antioxidants (Basel). 2021;10.
    PubMed    
    Abstract available

  36. ROGER I, Milara J, Montero P, Cortijo J, et al
    The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  37. WALIGORA M, Gliniak M, Bylica J, Pasieka P, et al
    Extended Precordial T Wave Inversions Are Associated with Right Ventricular Enlargement and Poor Prognosis in Pulmonary Hypertension.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  38. NARANJO M, Hassoun PM
    Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  39. LO GULLO A, Mandraffino G, Rodriguez-Carrio J, Scuruchi M, et al
    Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension.
    Biomedicines. 2021;9.
    PubMed    
    Abstract available

  40. MARULANDA K, Mercel A, Gillis DC, Sun K, et al
    Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice.
    Adv Healthc Mater. 2021 Jun 1:e2100302. doi: 10.1002/adhm.202100302.
    PubMed    
    Abstract available

  41. LAWRIE A, Francis SE
    Frataxin and endothelial cell senescence in pulmonary hypertension.
    J Clin Invest. 2021;131.
    PubMed    
    Abstract available

  42. JIN Q, Su H, Yang R, Tan Y, et al
    C1q/TNF-related protein-9 ameliorates hypoxia-induced pulmonary hypertension by regulating secretion of endothelin-1 and nitric oxide mediated by AMPK in rats.
    Sci Rep. 2021;11:11372.
    PubMed    
    Abstract available

  43. KAWASHIMA N, Fukasawa Y, Nishikawa E, Ohta-Ogo K, et al
    Echocardiography Monitoring of Pulmonary Hypertension after Pediatric Hematopoietic Stem Cell Transplantation: Pediatric PAH and PVOD after HSCT.
    Transplant Cell Ther. 2021 May 28. pii: S2666-6367(21)00936.
    PubMed    
    Abstract available

  44. ACHARYA AP, Tang Y, Bertero T, Tai YY, et al
    Simultaneous Pharmacologic Inhibition of Yes-Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic-co-Glycolic) Acid-Encapsulated Microparticles Improves Pulmonary Hypertension.
    J Am Heart Assoc. 2021 May 29:e019091. doi: 10.1161/JAHA.120.019091.
    PubMed    
    Abstract available

  45. SCHLEIN J, Riebandt J, Laufer G, Zimpfer D, et al
    Reversal of pulmonary hypertension in paediatric patients with restrictive cardiomyopathy.
    Interact Cardiovasc Thorac Surg. 2021 May 31. pii: 6289850.
    PubMed    
    Abstract available

  46. PIERCE CM, Zhang MH, Jonsson B, Iorga D, et al
    Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants With, or at Risk of Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial.
    J Pediatr. 2021 May 27. pii: S0022-3476(21)00502.
    PubMed    
    Abstract available

  47. WANG TM, Wang SS, Xu YJ, Zhao CM, et al
    SOX17 Loss-of-Function Mutation Underlying Familial Pulmonary Arterial Hypertension.
    Int Heart J. 2021;62:566-574.
    PubMed    
    Abstract available

  48. FRANTZ RP
    REPLACE and the role of riociguat in pulmonary arterial hypertension therapy.
    Lancet Respir Med. 2021;9:546-547.
    PubMed    


  49. JIANG Y, Liu H, Yu H, Zhou Y, et al
    Circular RNA Calm4 Regulates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cells Pyroptosis via the Circ-Calm4/miR-124-3p/PDCD6 Axis.
    Arterioscler Thromb Vasc Biol. 2021;41:1675-1693.
    PubMed    
    Abstract available

  50. SEGURA DE LA CAL T, Nuche J, Jimenez Lopez-Guarch C, Perez-Olivares C, et al
    COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
    Ann Am Thorac Soc. 2021;18:1080-1081.
    PubMed    


  51. LEE JD, Burger CD, Rayner SG, Ryan JJ, et al
    Reply: COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
    Ann Am Thorac Soc. 2021;18:1081-1082.
    PubMed    


  52. MADANI MH, Leung ANC, Becker HC, Chan FP, et al
    Aorto-iliac/right leg arterial thrombosis necessitating limb amputation, pulmonary arterial, intracardiac, and ilio-caval venous thrombosis in a 40-year-old with COVID-19.
    Clin Imaging. 2021;75:1-4.
    PubMed    
    Abstract available

  53. WILLIAMS TJ, McGiffin D
    'Surgery first' if cure is your aim in CTEPH.
    Respirology. 2021;26:140-142.
    PubMed    


  54. KNUDSEN AD, Ronit A, Kristensen T, Thomsen MT, et al
    Pulmonary arterial enlargement in well-treated persons with HIV.
    J Infect Dis. 2020 Jun 19. pii: 5860158. doi: 10.1093.
    PubMed    
    Abstract available

  55. LAZARO SALVADOR M, Quezada Loaiza CA, Rodriguez Padial L, Barbera JA, et al
    Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry.
    Intern Med J. 2021;51:355-365.
    PubMed    
    Abstract available

  56. AMBADE AS, Hassoun PM, Damico RL
    Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2021 Jun 15. doi: 10.1165/rcmb.2021-0091.
    PubMed    
    Abstract available

  57. ZHANG H, Peng YX, Sun YJ, Xu ZM, et al
    [Efficacy of emergent systemic-pulmonary arterial anastomosis (Potts shunt) in a child with severe idiopathic pulmonary hypertension].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2021;49:621-623.
    PubMed    


  58. BHAT R, Tirlangi PK, Ravindra P, Balakrishnan JM, et al
    The conundrum of Thiamine Responsive Acute Pulmonary Hypertension (TRAPH) syndrome in the Emergency Department.
    Am J Emerg Med. 2021;49:185-188.
    PubMed    
    Abstract available

  59. FABRO AT, Machado-Rugolo J, Baldavira CM, Prieto TG, et al
    Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension.
    Front Pharmacol. 2021;12:648769.
    PubMed    
    Abstract available

  60. MATSUOKA Y, Taniguchi Y, Miwa K, Sumimoto K, et al
    Reply to to the editor, in response to: Assessment of oxygenation after balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2021 Jun 9. pii: S0167-5273(21)00967.
    PubMed    


  61. ZHENG Z, Chen R, Zhong Y, Lu J, et al
    Oxygenation: An important indicator for evaluating the effect of treating pulmonary hypertension.
    Int J Cardiol. 2021 Jun 9. pii: S0167-5273(21)00964.
    PubMed    


  62. LU J, Chen R, Liu H, Hong C, et al
    Right atrial area to left atrial area ratio, a diagnostic and prognostic parameter worth studying in pulmonary hypertension due to left heart disease.
    Int J Cardiol. 2021 Jun 9. pii: S0167-5273(21)00965.
    PubMed    


  63. KEMPER DAG, Otsuki DA, Maia DRR, Mossoco CO, et al
    Sildenafil in endotoxin-induced pulmonary hypertension: an experimental study.
    Braz J Anesthesiol. 2021 Jun 9. pii: S0104-0014(21)00239.
    PubMed    
    Abstract available

  64. PATEL M, Daboul J, Iftikhar S, Burmeister C, et al
    Weight Loss Supplement-Induced Pulmonary Hypertension: A Decades Delayed Presentation of Fenfluramine-Phentermine.
    Am J Ther. 2021 Jun 1. pii: 00045391-900000000-98044.
    PubMed    


  65. DENIZ S, Uysal TK, Capasso C, Supuran CT, et al
    Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?
    J Enzyme Inhib Med Chem. 2021;36:1230-1235.
    PubMed    
    Abstract available

  66. FENG W, Wang J, Yan X, Zhang Q, et al
    ERK/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension.
    Cell Prolif. 2021;54:e13048.
    PubMed    
    Abstract available

  67. NAKAI R, Fujioka T, Okamura K, Suzuki T, et al
    Survival Outcomes of Two-Stage Intracardiac Repair in Large Ventricular Septal Defect and Trisomy 18.
    Pediatr Cardiol. 2021;42:821-831.
    PubMed    
    Abstract available

  68. EDRAKI M, Ghasemzadeh B, Keshavarz K, Amirghofran A, et al
    Hidden pulmonary arteries in tetralogy of Fallot and pulmonary artery pressure in patients operated with a pulmonary artery.
    BMC Cardiovasc Disord. 2021;21:56.
    PubMed    
    Abstract available

  69. KANWAR MK, Cole M, Gauthier-Loiselle M, Manceur AM, et al
    Development and validation of a claims-based model to identify patients at risk of chronic thromboembolic pulmonary hypertension following acute pulmonary embolism.
    Curr Med Res Opin. 2021 Jun 24:1-33. doi: 10.1080/03007995.2021.1947215.
    PubMed    
    Abstract available

  70. KAINUMA S, Toda K, Miyagawa S, Yoshikawa Y, et al
    Detrimental effects of elevated transpulmonary gradient on outcomes following restrictive mitral annuloplasty in patients with pre-existing pulmonary hypertension.
    J Thorac Dis. 2021;13:2746-2757.
    PubMed    
    Abstract available

  71. JOHNSON K, VandenHull A, Remund T, Pohlson K, et al
    Short-term Cost Comparison of Systemic Heparin Therapy vs. Catheter Directed Thrombolysis for the Treatment of Massive and Submassive Pulmonary Embolism with Long-Term Chronic Pulmonary Hypertension Cost Model.
    S D Med. 2021;74:70-74.
    PubMed    
    Abstract available

  72. SUN H, Paudel O, Sham JSK
    Increased intracellular Cl(-) Concentrations in Pulmonary Arterial Myocytes Associated with Chronic Hypoxic Pulmonary Hypertension.
    Am J Physiol Cell Physiol. 2021 Jun 23. doi: 10.1152/ajpcell.00172.2021.
    PubMed    
    Abstract available

  73. BALDI BG, Fernandes CJCDS, Heiden GI, Freitas CSG, et al
    Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases.
    Medicine (Baltimore). 2021;100:e26483.
    PubMed    
    Abstract available

  74. DUBROCK HM, Burger CD, Bartolome SD, Feldman JP, et al
    Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry.
    Pulm Circ. 2021;11:20458940211020913.
    PubMed    
    Abstract available

  75. YANG Q, Zhang Z, Liao J, Zhang J, et al
    The causality between CFTR and pulmonary hypertension: insights from Mendelian randomization studies.
    Hypertens Res. 2021 Jun 21. pii: 10.1038/s41440-021-00680.
    PubMed    


  76. MIAO R, Dong X, Gong J, Li Y, et al
    Cell landscape atlas for patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy constructed using single-cell RNA sequencing.
    Aging (Albany NY). 2021;13.
    PubMed    
    Abstract available

  77. MILTON AD, Almazroue H, Jin Y, Zender G, et al
    DDAH1 SNP rs480414 that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia results in lower nitric oxide production in neonatal cord blood-derived lymphoblastoid cell lines.
    J Neonatal Perinatal Med. 2021 Jun 17. pii: NPM210710. doi: 10.3233/NPM-210710.
    PubMed    
    Abstract available

  78. WANG F, Quan Q
    Anti-inflammatory role and mechanism of microRNA-92b-3p in the progression of hypoxic pulmonary hypertension.
    Life Sci. 2021 Jun 16:119725. doi: 10.1016/j.lfs.2021.119725.
    PubMed    
    Abstract available

  79. VENKATESHVARAN A, Seidova N, Tureli HO, Kjellstrom B, et al
    Accuracy of echocardiographic estimates of pulmonary artery pressures in pulmonary hypertension: insights from the KARUM hemodynamic database.
    Int J Cardiovasc Imaging. 2021 Jun 19. pii: 10.1007/s10554-021-02315.
    PubMed    
    Abstract available

  80. SCANLON KM, Chen L, Carbonetti NH
    Pertussis toxin promotes pulmonary hypertension in an infant mouse model of Bordetella pertussis infection.
    J Infect Dis. 2021 Jun 19. pii: 6305603. doi: 10.1093.
    PubMed    
    Abstract available

  81. BRENER MI, Hamid NB, Sunagawa K, Borlaug BA, et al
    Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action from the HELP Trial.
    J Card Fail. 2021 Jun 15. pii: S1071-9164(21)00215.
    PubMed    


  82. LOPEZ-CRISOSTO C, Arias-Carrasco R, Sepulveda P, Garrido-Olivares L, et al
    Novel molecular insights and public omics data in pulmonary hypertension.
    Biochim Biophys Acta Mol Basis Dis. 2021 Jun 15:166200.
    PubMed    
    Abstract available

  83. SHARMA C, Burns J, Kulkarni A, Cerise JE, et al
    Continuous and intermittent administration of intravenous sildenafil in critically ill infants with pulmonary hypertension.
    Pediatr Pulmonol. 2021 Jun 18. doi: 10.1002/ppul.25539.
    PubMed    
    Abstract available

  84. BLASI FBM, Rota I, Graziadei G, Vicenzi M, et al
    The tailor-made treatment in a particular case of pulmonary hypertension in thalassaemia intermedia: a case report.
    Eur Heart J Case Rep. 2021;5:ytab193.
    PubMed    
    Abstract available

  85. SCHUSSLER A, Richter M, Tello K, Steiner D, et al
    Evaluation of Diagnostic Accuracy and Radiation Exposure of Dual-Energy Computed Tomography (DECT) in the Course of Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
    Rofo. 2021 Jun 17. doi: 10.1055/a-1502-7541.
    PubMed    
    Abstract available

  86. NAGAMATSU Y, Goda A, Ito J, Takeuchi K, et al
    Novel diagnostic and therapeutic approaches to pulmonary hypertension due to the unilateral absence of a pulmonary artery.
    ESC Heart Fail. 2021 Jun 16. doi: 10.1002/ehf2.13459.
    PubMed    
    Abstract available

  87. PRIYA S, Aggarwal T, Ward C, Bathla G, et al
    Radiomics side experiments and DAFIT approach in identifying pulmonary hypertension using Cardiac MRI derived radiomics based machine learning models.
    Sci Rep. 2021;11:12686.
    PubMed    
    Abstract available

  88. PARK JH, Na JO, Lee JS, Kim YH, et al
    2020 KSC/KATRD guideline for the diagnosis and treatment of pulmonary hypertension: Executive summary.
    Tuberc Respir Dis (Seoul). 2021 Jun 4. pii: trd.2021.0022.
    PubMed    
    Abstract available

  89. ZHAO H, Guo A, Wang M, Cai Z, et al
    The Influence of Bosentan on MicroRNA-27a/PPARgamma/ET-1 Signaling Pathway in Pulmonary Artery Hypertension.
    Pediatr Cardiol. 2021;42:1141-1148.
    PubMed    
    Abstract available

  90. LIU J, Sun Y, Zhu B, Lin Y, et al
    Identification of a potentially novel LncRNA-miRNA-mRNA competing endogenous RNA network in pulmonary arterial hypertension via integrated bioinformatic analysis.
    Life Sci. 2021;277:119455.
    PubMed    
    Abstract available

  91. HOEPER MM, Al-Hiti H, Benza RL, Chang SA, et al
    Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
    Lancet Respir Med. 2021;9:573-584.
    PubMed    
    Abstract available

  92. TAN Y, Wang S, Ren X, Zhang C, et al
    The prognostic implications of perioperative endogenous hydrogen sulfide and nitric oxide levels in children with congenital heart disease complicated by pulmonary arterial hypertension.
    Eur J Pediatr. 2021 Feb 8. pii: 10.1007/s00431-020-03897.
    PubMed    
    Abstract available

  93. BOUTOU AK, Panagiotidou E, Zacharias A, Stanopoulos I, et al
    Early Pulmonary Rehabilitation after Pulmonary Endarterectomy: Both Safe and Effective?
    Respiration. 2021;100:182-183.
    PubMed    


  94. ZHANG C, Lu W, Luo X, Liu S, et al
    Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats.
    Br J Pharmacol. 2021;178:217-235.
    PubMed    
    Abstract available

  95. WU J, Lu Y, Zhao W, Shen J, et al
    Clinical characteristics and therapeutic outcomes of pulmonary arterial hypertension secondary to congenital portosystemic shunts.
    Eur J Pediatr. 2020 Oct 3. pii: 10.1007/s00431-020-03817.
    PubMed    
    Abstract available

  96. PALOMEQUE A, Vollmer I, Fontana A, Lucena CM, et al
    Focal Mediastinitis and Pulmonary Arterial Thrombosis after EBUS-TBNA.
    Arch Bronconeumol (Engl Ed). 2021;57:73-74.
    PubMed    


  97. KORBITZ PM, Gallagher JP, Samant H, Singh S, et al
    Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: Meta-analysis.
    Clin Transplant. 2020 Jun 2:e13995. doi: 10.1111/ctr.13995.
    PubMed    
    Abstract available

  98. HARBAUM L, Rhodes CJ, Otero-Nunez P, Wharton J, et al
    The application of 'omics' to pulmonary arterial hypertension.
    Br J Pharmacol. 2021;178:108-120.
    PubMed    
    Abstract available

  99. SOMMER N, Ghofrani HA, Pak O, Bonnet S, et al
    Current and future treatments of pulmonary arterial hypertension.
    Br J Pharmacol. 2021;178:6-30.
    PubMed    
    Abstract available

  100. DZIKOWSKA-DIDUCH O, Kostrubiec M, Kurnicka K, Lichodziejewska B, et al
    "The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism".
    Thromb Res. 2019;186:30-35.
    PubMed    
    Abstract available

  101. MAMAZHAKYPOV A, Viswanathan G, Lawrie A, Schermuly RT, et al
    The role of chemokines and chemokine receptors in pulmonary arterial hypertension.
    Br J Pharmacol. 2021;178:72-89.
    PubMed    
    Abstract available

  102. WANG JK, Chiu SN, Lin MT, Chen CA, et al
    Transcatheter Closure of Atrial Septal Defect Associated with Pulmonary Artery Hypertension using Fenestrated Devices.
    Am J Cardiol. 2021 Mar 2. pii: S0002-9149(21)00096.
    PubMed    
    Abstract available

  103. SCHAFER M, Ivy DD, Nguyen K, Boncella KL, et al
    Metalloproteinases and Their Inhibitors Are Associated with Pulmonary Arterial Stiffness and Ventricular Function in Pediatric Pulmonary Hypertension.
    Am J Physiol Heart Circ Physiol. 2021 Jun 4. doi: 10.1152/ajpheart.00750.2020.
    PubMed    
    Abstract available

  104. FERGUSON BS, Wennersten SA, Demos-Davies KM, Rubino M, et al
    DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
    Am J Physiol Heart Circ Physiol. 2021 Jun 18. doi: 10.1152/ajpheart.00115.2021.
    PubMed    
    Abstract available

  105. COLEBANK MJ, Qureshi MU, Rajagopal S, Krasuski RA, et al
    A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2021 Jun 18. doi: 10.1152/ajpheart.00086.2021.
    PubMed    
    Abstract available

  106. YAMASAKI Y, Kamitani T, Abe K, Hosokawa K, et al
    Diagnosis of Pulmonary Hypertension Using Dynamic Chest Radiography.
    Am J Respir Crit Care Med. 2021 Jun 8. doi: 10.1164/rccm.202102-0387.
    PubMed    


  107. KILICKIRAN AVCI B, Ozden Tok O, Kalangos A, Alkan Bozkaya T, et al
    A 19-Year-Old Pregnant Woman With Pulmonary Hypertension With Progressive Dyspnea.
    Chest. 2021;159:e371-e375.
    PubMed    
    Abstract available

  108. FORD HJ, LeVarge B
    The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite?
    Chest. 2021;159:14-16.
    PubMed    


  109. BENZA RL, Kanwar MK, Raina A, Scott JV, et al
    Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.
    Chest. 2021;159:337-346.
    PubMed    
    Abstract available

  110. DUBROCK HM, Cartin-Ceba R, Channick RN, Kawut SM, et al
    Sex Differences in Portopulmonary Hypertension.
    Chest. 2021;159:328-336.
    PubMed    
    Abstract available

  111. THAYER TE, Levinson RT, Huang S, Assad T, et al
    BMI Is Causally Associated With Pulmonary Artery Pressure But Not Hemodynamic Evidence of Pulmonary Vascular Remodeling.
    Chest. 2021;159:302-310.
    PubMed    
    Abstract available

  112. SUN F, Wang G, Pradhan A, Xu K, et al
    Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2021 Jun 11. doi: 10.1161/CIRCULATIONAHA.121.053980.
    PubMed    
    Abstract available

  113. SATOH T, Wang L, Espinosa-Diez C, Wang B, et al
    Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Down Regulation of sGC and Contributes to Exercise-Induced Pulmonary Hypertension in HFpEF.
    Circulation. 2021 Jun 23. doi: 10.1161/CIRCULATIONAHA.121.053889.
    PubMed    
    Abstract available

  114. SAMARANAYAKE CB, McCabe C, Wort SJ, Price LC, et al
    Sarcoidosis associated pulmonary hypertension: an update.
    Curr Opin Pulm Med. 2021 Jun 11. pii: 00063198-900000000-98962.
    PubMed    
    Abstract available

  115. BEHR J, Nathan SD
    Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment.
    Curr Opin Pulm Med. 2021 Jun 14. pii: 00063198-900000000-98958.
    PubMed    
    Abstract available

  116. STEWART S, Chan YK, Playford D, Strange GA, et al
    Mild pulmonary hypertension and premature mortality among 154 956 men and women undergoing routine echocardiography.
    Eur Respir J. 2021 May 28. pii: 13993003.00832-2021.
    PubMed    
    Abstract available

  117. ABMAN SH, Mullen MP, Sleeper LA, Austin ED, et al
    Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry.
    Eur Respir J. 2021 Jun 17. pii: 13993003.03337-2020.
    PubMed    
    Abstract available

  118. BETHOU A
    Utility of Nebulized Magnesium Sulfate Therapy for Persistent Pulmonary Hypertension of Newborn.
    Indian J Pediatr. 2021 Jun 23. pii: 10.1007/s12098-021-03851.
    PubMed    


  119. MOHER ALSADY T, Kaireit TF, Behrendt L, Winther HB, et al
    Comparison of dual-energy computer tomography and dynamic contrast-enhanced MRI for evaluating lung perfusion defects in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2021;16:e0251740.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;